HC Wainwright Lowers Cytokinetics (NASDAQ:CYTK) Price Target to $90.00
Cytokinetics (NASDAQ:CYTK – Get Free Report) had its target price dropped by equities researchers at HC Wainwright from $94.00 to $90.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 86.34% from the company’s […]